These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27317099)

  • 21. Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K/AKT pathway.
    Hao J; Yang Z; Wang L; Zhang Y; Shu Y; Jiang L; Hu Y; Lv W; Dong P; Liu Y
    Int J Oncol; 2017 Sep; 51(3):823-831. PubMed ID: 28766687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance to EGFR-targeted therapy through Src kinase activation.
    Lee SH; Kim JM; Lee DG; Lee J; Park JG; Han TS; Cho HS; Cho YL; Bae KH; Park YJ; Lee SJ; Lee MS; Huh YM; Jo DY; Yun HJ; Jeon HJ; Kim N; Joo M; Kim JS; Lee HJ; Min JK
    Cell Death Differ; 2021 Mar; 28(3):968-984. PubMed ID: 32989241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1.
    Wang JW; Peng SY; Li JT; Wang Y; Zhang ZP; Cheng Y; Cheng DQ; Weng WH; Wu XS; Fei XZ; Quan ZW; Li JY; Li SG; Liu YB
    Cancer Lett; 2009 Aug; 281(1):71-81. PubMed ID: 19299076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
    Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
    Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer.
    Zhou Z; Peng Y; Wu X; Meng S; Yu W; Zhao J; Zhang H; Wang J; Li W
    Cell Oncol (Dordr); 2019 Feb; 42(1):81-92. PubMed ID: 30276551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing.
    Li M; Chen L; Qu Y; Sui F; Yang Q; Ji M; Shi B; Chen M; Hou P
    Oncotarget; 2017 May; 8(22):36319-36330. PubMed ID: 28422736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1.
    Lu W; Hu Y; Ma Q; Zhou L; Jiang L; Li Z; Zhao S; Xu Y; Shi W; Li S; Liu Y
    Oncotarget; 2016 Sep; 7(38):62364-62376. PubMed ID: 27577078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder Cancer.
    Liang HB; Cao Y; Ma Q; Shu YJ; Wang Z; Zhang F; Ye YY; Li HF; Xiang SS; Song XL; Xu Y; Zhang YC; Bao RF; Yuan RY; Zhang YJ; Hu YP; Jiang L; Li ML; Wang XA; Wu XS; Wu WG; Zhao S; Fand Y; Cui XP; Lu YS; Zhou J; Zheng L; Gong W; Liu YB
    Cell Physiol Biochem; 2017; 41(5):2117-2131. PubMed ID: 28427077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. cIAP2 promotes gallbladder cancer invasion and lymphangiogenesis by activating the NF-κB pathway.
    Jiang X; Li C; Lin B; Hong H; Jiang L; Zhu S; Wang X; Tang N; Li X; She F; Chen Y
    Cancer Sci; 2017 Jun; 108(6):1144-1156. PubMed ID: 28295868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional role of SGK3 in PI3K/Pten driven liver tumor development.
    Cao H; Xu Z; Wang J; Cigliano A; Pilo MG; Ribback S; Zhang S; Qiao Y; Che L; Pascale RM; Calvisi DF; Chen X
    BMC Cancer; 2019 Apr; 19(1):343. PubMed ID: 30975125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling.
    Qin Y; Meng L; Fu Y; Quan Z; Ma M; Weng M; Zhang Z; Gao C; Shi X; Han K
    Oncotarget; 2017 Mar; 8(12):19980-19996. PubMed ID: 28212545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo.
    Jung J; Son YS; Park H; Jeon SK; Lee JW; Choi SY; Kim JM; Kwon YG; Hong HJ; Min JK
    Oncol Rep; 2011 Apr; 25(4):945-52. PubMed ID: 21318226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ponicidin inhibited gallbladder cancer proliferation and metastasis by decreasing MAGEB2 expression through FOXO4.
    Zhao C; Zhang J; Yang ZY; Shi LQ; Liu SL; Pan LJ; Dong P; Zhang Y; Xiang SS; Shu YJ; Mei JW
    Phytomedicine; 2023 Jun; 114():154785. PubMed ID: 37002972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway.
    Shen S; Liu H; Wang Y; Wang J; Ni X; Ai Z; Pan H; Liu H; Shao Y
    Oncotarget; 2016 Nov; 7(45):72833-72844. PubMed ID: 27637083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation-Associated Phenotypic Heterogeneity in Novel and Canonical PIK3CA Helical and Kinase Domain Mutants.
    Ghodsinia AA; Lego JMT; Garcia RL
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancy.
    Hu MT; Wang JH; Yu Y; Liu C; Li B; Cheng QB; Jiang XQ
    Int J Oncol; 2018 Sep; 53(3):1215-1226. PubMed ID: 30015925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HASPIN is involved in the progression of gallbladder carcinoma.
    Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L
    Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma.
    Zhang P; Cao P; Zhu X; Pan M; Zhong K; He R; Li Y; Jiao X; Gao Y
    Oncotarget; 2017 May; 8(20):33137-33143. PubMed ID: 28388535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells.
    Shi Y; Sun L; Zhang R; Hu Y; Wu Y; Dong X; Dong D; Chen C; Geng Z; Li E; Fan Y
    J Exp Clin Cancer Res; 2021 Jan; 40(1):14. PubMed ID: 33407730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.